StockData
SRTANasdaqServices-Health ServicesFiscal year ends December 31

Strata Critical Medical, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$4.54+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
$391.41M
P/E (TTM)
8.9
Dividend yield
–

Strata Critical Medical, Inc. revenue by segment

By business segment

RevenueQ2 26Q1 26Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23Q2 23Q1 23% of revenueYoY
Logistics$48.24M$47.60M$45.11M$35.95M––––––––66.5%+6.9%
Clinical$24.27M$19.79M$0$0––––––––33.5%–
Passenger––$25.69M$18.36M$17.97M$38.82M$29.60M$15.49M$15.49M$38.00M$26.59M$18.50M––
Medical Segment––$45.11M$35.95M$36.39M$36.06M$38.34M$36.03M$31.99M$33.45M$34.40M$26.77M––
Operating incomeQ2 26Q1 26Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23Q2 23Q1 23YoY
Passenger––––––––-$25.35M$801.00K-$3.84M-$5.12M–
Medical Segment––––––––-$2.44M-$85.00K-$497.00K$1.64M–

By product or service

By region

RevenueQ2 26Q1 26Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23Q2 23Q1 23% of revenueYoY
United States––$62.45M$48.37M$52.16M$63.28M$58.00M$45.30M$42.12M$58.63M$51.99M$38.00M––
Other––$8.36M$5.94M$2.19M$11.60M$9.95M$6.21M$5.35M$12.81M$9.00M$7.27M––

From the segment and revenue-disaggregation notes of Strata Critical Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.